Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Share-based Compensation (2010 - 2025)

Siga Technologies' (SIGA) quarterly Share-based Compensation came in at $774104.0 in Q3 2025, down 4.87% on a YoY basis from $813774.0 in Q3 2024, and down 37.29% quarter-over-quarter from $1.2 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Share-based Compensation (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Share-based Compensation for 16 consecutive years, with $774104.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation fell 4.87% year-over-year to $774104.0; the trailing twelve-month figure through Sep 2025 stood at $3.7 million (up 8.53% YoY), and the FY2024 full-year result was $3.6 million, up 73.34% from the prior year.
  • Share-based Compensation slipped to $774104.0 in Q3 2025 per SIGA's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $1.2 million in Q2 2025 and bottomed at $243503.0 in Q3 2021.
  • Historically, Share-based Compensation has averaged $618471.8 across 5 years, with a median of $510007.0 in 2023.
  • The sharpest annual moves came in 2021 and 2024: Share-based Compensation sank 36.06% in 2021, then soared 176.47% in 2024.
  • Over 5 years, Share-based Compensation stood at $342680.0 in 2021, then surged by 106.35% to $707107.0 in 2022, then retreated by 27.87% to $510007.0 in 2023, then surged by 49.82% to $764070.0 in 2024, then rose by 1.31% to $774104.0 in 2025.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $774104.0, $1.2 million, and $902280.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn -950.00 Mn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 166.00 Mn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 249.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -
7 Revolution Medicines 43.79 Bn 43.79 Bn - 277.20 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 67.26 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 19.00 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 774,104.00
Jun 30, 2025 1.23 Mn
Mar 31, 2025 902,280.00
Dec 31, 2024 764,070.00
Sep 30, 2024 813,774.00
Jun 30, 2024 932,287.00
Mar 31, 2024 1.13 Mn
Dec 31, 2023 510,007.00
Sep 30, 2023 459,823.00
Jun 30, 2023 721,440.00
Mar 31, 2023 408,730.00
Dec 31, 2022 707,107.00
Sep 30, 2022 328,685.00
Jun 30, 2022 395,454.00
Mar 31, 2022 368,754.00
Dec 31, 2021 342,680.00
Sep 30, 2021 243,503.00
Jun 30, 2021 467,405.00
Mar 31, 2021 246,412.00
Dec 31, 2020 436,628.00